IKSA experts visited Minhai Biotechnology to assess the operation of its quality management system.

Release date:

2019-03-29

Author:

Source:


Abstract

From March 18 to 22, 2019, a three-member IKSA expert team visited Minhai to assess the operation of its quality management system. Minhai’s General Manager Zheng Haifa, Executive Deputy General Manager Liu Jiankai, Vice President of Quality Li Xiangqun, Vice President of Production Nie Xiaoqi, and other relevant department heads extended a warm welcome to the IKSA experts.

  From March 18 to 22, 2019, a three-member IKSA expert team visited Minhai to assess the operation of its quality management system. Minhai’s General Manager Zheng Haifa, Executive Deputy General Manager Liu Jiankai, Vice President of Quality Li Xiangqun, Vice President of Production Nie Xiaoqi, and other relevant department heads extended a warm welcome to the IKSA experts.

  Zhang Qian from Minhai’s International Cooperation Department presented an overview of the company to the IKSA expert panel. Subsequently, using the Hib conjugate vaccine as a case study, the panel divided into three groups—Quality Assurance, Quality Control, and the Manufacturing Workshop (including the Hib production unit, the secondary packaging unit, and the Engineering and Equipment Department)—to conduct an analysis of the gaps between the company’s quality system and WHO requirements.

  After five days of rigorous inspection, the IKSA expert panel issued a truthful, detailed, and comprehensive analysis and summary report on the operation of our company’s quality management system. The report provided valuable recommendations to help us achieve WHO pre‑qualification in the future, while also setting higher and more stringent requirements for our quality assurance system. Company leadership stated that we must, in strict accordance with WHO standards, strengthen our quality awareness and enhance our quality management system to ensure product quality in a thorough and systematic manner.

 

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09